Medical Xpress on MSN9d
Study Paves Way for Off-the-Shelf Cancer CAR T-Cell TherapyNow research done at Memorial Sloan Kettering Cancer Center (MSK) has demonstrated a new advance that could make it possible ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
5d
News Medical on MSNThe CAR T Veteran: A Journey of Resilience, Remission, and AdvocacyLaurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...
Despite the powerful cancer-fighting capabilities of treatments based on CAR-T cells to fight a patient’s cancer, one key challenge is getting these treatments to more patients.
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results